The fact that PIK3CA mutations and PTEN loss are nearly mutually exclusive implies that deregulated PIP3 is critical for tumorigenesis in breast cancers and that loss of PIP3 homeostasis by abrogation of either PIK3CA or PTEN relieves selective pressure for targeting of the other gene [39]. This evidence concerns the gene PTEN and breast cancer.